Global Medical REIT Inc. is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company's management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers. The Company elected to be taxed as a REIT for U.S. federal income tax purposes commencing with its taxable year ending December 31, 2016.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
SymbolNYSE:GMRE
CUSIPN/A
Phone202-524-6851
Debt
Debt-to-Equity Ratio1.63
Current Ratio0.14
Quick Ratio0.14
Price-To-Earnings
Trailing P/E Ratio17.59
Forward P/E Ratio11.45
P/E Growth1.26
Sales & Book Value
Annual Sales$30.34 million
Price / Sales6.77
Cash Flow$0.5284 per share
Price / Cash17.98
Book Value$8.51 per share
Price / Book1.12
Profitability
EPS (Most Recent Fiscal Year)$0.54
Net Income$-30,000.00
Net Margins8.00%
Return on Equity1.91%
Return on Assets0.67%
Miscellaneous
Employees9
Outstanding Shares21,630,000
Market Cap$203.33 million
Global Medical REIT (NYSE:GMRE) Frequently Asked Questions
What is Global Medical REIT's stock symbol?
Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."
How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?
Global Medical REIT announced a quarterly dividend on Friday, June 15th. Investors of record on Tuesday, June 26th will be paid a dividend of $0.20 per share on Wednesday, July 11th. This represents a $0.80 annualized dividend and a dividend yield of 8.42%. The ex-dividend date of this dividend is Monday, June 25th. View Global Medical REIT's Dividend History.
How were Global Medical REIT's earnings last quarter?
Global Medical REIT Inc (NYSE:GMRE) announced its quarterly earnings data on Tuesday, August, 7th. The company reported $0.19 EPS for the quarter, missing the Zacks' consensus estimate of $0.20 by $0.01. The business had revenue of $13.25 million for the quarter, compared to analyst estimates of $12.86 million. Global Medical REIT had a net margin of 8.00% and a return on equity of 1.91%. View Global Medical REIT's Earnings History.
When is Global Medical REIT's next earnings date?
What price target have analysts set for GMRE?
5 analysts have issued twelve-month price targets for Global Medical REIT's shares. Their forecasts range from $8.00 to $12.00. On average, they expect Global Medical REIT's share price to reach $10.3750 in the next twelve months. This suggests a possible upside of 9.2% from the stock's current price. View Analyst Price Targets for Global Medical REIT.
What is the consensus analysts' recommendation for Global Medical REIT?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Global Medical REIT.
What are Wall Street analysts saying about Global Medical REIT stock?
Here are some recent quotes from research analysts about Global Medical REIT stock:
- 1. According to Zacks Investment Research, "Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. " (8/14/2018)
- 2. Cantor Fitzgerald analysts commented, "GMRE reported in-line 4Q17 results in a relatively clean but active quarter in terms of M&A and balance sheet developments." (3/7/2018)
Who are some of Global Medical REIT's key competitors?
Some companies that are related to Global Medical REIT include Granite Point Mortgage Trust (GPMT), CBL & Associates Properties (CBL), CAPSTEAD Mtg Co/SH (CMO), Pennsylvania R.E.I.T. (PEI), Urstadt Biddle Properties (UBP), Preferred Apartment Communities (APTS), istar (STAR), Northstar Realty Europe (NRE), NexPoint Residential Trust (NXRT), CIM Commercial Trust (CMCT), INVESTORS REAL ESTATE TRUST REIT Common Stock (IRET), Ashford Hospitality Trust (AHT), Essential Properties Realty Trust (EPRT), UMH PROPERTIES/SH SH (UMH) and Catchmark Timber Trust (CTT).
Who are Global Medical REIT's key executives?
Global Medical REIT's management team includes the folowing people:
- Mr. Jeffrey M. Busch, Chairman, CEO & Pres (Age 58)
- Mr. David A. Young, Consultant (Age 70)
- Mr. Robert J. Kiernan, CFO & Treasurer (Age 52)
- Ms. Danica Holley, Chief Operating Officer (Age 45)
- Mr. Alfonzo Leon, Chief Investment Officer (Age 42)
When did Global Medical REIT IPO?
(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.
Has Global Medical REIT been receiving favorable news coverage?
News articles about GMRE stock have trended somewhat positive this week, according to Accern Sentiment. The research firm rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Global Medical REIT earned a coverage optimism score of 0.21 on Accern's scale. They also gave headlines about the company an impact score of 45.27 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for Global Medical REIT.
Who are Global Medical REIT's major shareholders?
Global Medical REIT's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.67%), RMR Advisors LLC (2.02%), State of New Jersey Common Pension Fund D (1.98%), Bank of New York Mellon Corp (0.85%), Renaissance Technologies LLC (0.80%) and Millennium Management LLC (0.69%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch and Matthew Cypher. View Institutional Ownership Trends for Global Medical REIT.
Which major investors are selling Global Medical REIT stock?
Which major investors are buying Global Medical REIT stock?
GMRE stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., State of New Jersey Common Pension Fund D, RMR Advisors LLC, Citadel Advisors LLC, Renaissance Technologies LLC, Schwab Charles Investment Management Inc. and Bank of New York Mellon Corp. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch and Matthew Cypher. View Insider Buying and Selling for Global Medical REIT.
How do I buy shares of Global Medical REIT?
Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Global Medical REIT's stock price today?
One share of GMRE stock can currently be purchased for approximately $9.50.
How big of a company is Global Medical REIT?
Global Medical REIT has a market capitalization of $203.33 million and generates $30.34 million in revenue each year. The company earns $-30,000.00 in net income (profit) each year or $0.54 on an earnings per share basis. Global Medical REIT employs 9 workers across the globe.
How can I contact Global Medical REIT?
Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.
MarketBeat Community Rating for Global Medical REIT (NYSE GMRE)
MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote "Outperform" if you believe GMRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
